OUR INITIATIVES
Our purpose is to help spread awareness, education, and research for underfunded rare cancers.
The purpose of The Laughlin Family Foundation is to help spread awareness, education, and research for underfunded/ rare cancers.
While there are many different types of rare cancers, one of the foundation’s first initiatives is to benefit gynecologic oncology (GYNONC).
There is a critical unmet need to fund research and support programs for women’s rare gynecological cancers, such as cervical, fallopian, ovarian, uterine, vaginal, and vulvar.
Every 6 minutes, a woman in the U.S. will be diagnosed with a gynecologic cancer.
Every 15 minutes, a woman in the U.S. will be diagnosed with a rare gynecologic cancer.
And while gynecological cancer research does receive annual funding from the National Institute of Health, it’s not enough.
NIH provides $305 million in total annual funding to support gynecological cancer research.
But provides $754 million for just breast cancer alone…that’s more than double than what’s provided for ALL gynecological cancers combined!
We need to start thinking “Below the Belt”.
There’s no doubt that doctors and researchers have made great advancements surrounding cancer care and research, having caused the number of most cancers and solid tumors to decrease or plateau in the last several years. But not all have seen a decline.
In fact, there has been an alarming rise of uterine and ovarian rates over the last 30 years, especially in the rare and aggressive forms of these cancers.
Women’s cancer is more than just breast cancer, and we need to start thinking “below the belt!” We need to help save women’s lives.
We need to start thinking about our mothers, sisters, and daughters. And since The Laughlin Family Foundation believes that every cancer deserves a voice, we want to raise awareness through education and community outreach, and fund essential research to improve screening and treatment options for women’s GYNOC.
Make a donation.
Every cancer deserves a voice. Help us give a voice to rare cancers and fund research initiatives for better education and awareness for rare cancers.